top of page
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
NPC231
Nasopharyngeal carcinoma tissue array, NPC231, non-overlapping with other NPC tissue arrays, containing 21 cases of primary tumors and 2 cases of metastatic tumors.
Price per slide:
$201
Species:
Human
Cases:
23
Cores:
23
Core Size:
1.5mm
Core Thickness:
4um
Rows:
3
Columns:
8
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in nasopharyngeal carcinoma.
3
X
8
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A02 |  | M | 53 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A03 |  | M | 32 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A04 |  | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A05 |  | M | 54 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A06 |  | M | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
A07 |  | M | 62 | Head and neck, nasopharynx | Non-keratinizing differentiated carcinoma | Malignant | II | |
A08 |  | F | 35 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B01 |  | F | 45 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B02 |  | M | 49 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B03 |  | M | 38 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B04 |  | F | 67 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B05 |  | F | 50 | Head and neck, left neck, subcutaneous tissue | Metastatic or invasive Non-keratinizing undifferentiated carcinoma | Metastasis | III | |
B06 |  | M | 60 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B07 |  | M | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
B08 |  | M | 66 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
C01 |  | F | 36 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
C02 |  | M | 42 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
C03 |  | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
C04 |  | F | 51 | Head and neck, nasopharynx | Non-keratinizing differentiated carcinoma | Malignant | II | |
C05 |  | F | 50 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III | |
C06 |  | M | 33 | Head and neck, mastoid process | Metastatic or invasive Non-keratinizing undifferentiated carcinoma | Metastasis | III | |
C07 |  | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | Malignant | III |
bottom of page